TrialBlood advances2021

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial.

Peter Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.